John F Mitchell, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 555 Harrison St, Emmaus, PA 18049 Phone: 610-965-6418 Fax: 610-965-6382 |
News Archive
Lucideon, the international materials technology company, welcomes three international students on the 7th framework European project ‘Biodensol'. The three students involved with the project have now begun an intense training period before they embark on developing novel glass, ceramic and sol-gel powders with dental applications.
Developing World Health (DWH), a leading medical charity based in Stirlingshire, Scotland and committed to developing effective treatments for neglected tropical diseases, has signed a collaboration agreement with the internationally respected Consortium for Parasitic Drug Development (CPDD), based at The University of North Carolina at Chapel Hill.
Nanoparticle delivery of diphtheria toxin-encoding DNA selectively expressed in ovarian cancer cells reduced the burden of ovarian tumors in mice, and researchers expect this therapy could be tested in humans within 18 to 24 months, according to a report in Cancer Research, a journal of the American Association for Cancer Research.
Reed Technology and Information Services Inc., a LexisNexis® business, today announced the introduction of LabelDataPlus™ – a comprehensive drug label database available on the Web for both industry and consumer use. LabelDataPlus offers more than 5,000 current and archived FDA-approved drug labels – the same drug information found on the National Library of Medicine's DailyMed web site – combined with powerful search features that unlock the information contained in drug labels (package inserts).
Mylan Inc. today announced that it has entered into a settlement agreement with Shionogi Inc. and CIMA Labs Inc. that will resolve patent litigation related to Prednisolone Sodium Phosphate Orally Disintegrating Tablets (ODT), 10 mg, 15 mg and 30 mg.
› Verified 6 days ago